Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRA-027 Administered to Healthy Japanese Females
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to assess the safety and tolerability of ascending
single oral doses of PRA-027 in healthy Japanese females. The secondary purpose is to provide
the initial pharmacokinetic and pharmacodynamic profiles of PRA-027 in healthy Japanese
female subjects.